MiNK Therapeutics, Inc. (INKT)

MiNK Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	4.58	3.37	19.64	38.89	2.69
Cash & Short-Term Investments	4.58	3.37	19.64	38.89	2.69
Cash Growth	35.93%	-82.85%	-49.51%	1345.06%	799.94%
Other Receivables	-	-	-	-	0.25
Receivables	-	-	-	-	0.25
Prepaid Expenses	0.25	0.05	0.3	0	0.49
Other Current Assets	0.16	0.18	0.47	0.74	0.66
Total Current Assets	4.99	3.6	20.4	39.63	4.1
Property, Plant & Equipment	0.73	0.95	1.07	0.61	0.46
Total Assets	5.72	4.55	21.47	40.24	4.56
Accounts Payable	2.73	3.91	5.82	3	3.14
Accrued Expenses	1.87	5.04	4.24	1.76	1.86
Other Current Liabilities	2.36	2.45	2.62	11.71	9.22
Total Current Liabilities	6.96	11.4	12.68	16.47	14.22
Long-Term Debt	4.92	-	-	-	43.82
Other Long-Term Liabilities	13.42	11.21	9.19	-	0.38
Total Liabilities	25.31	22.61	21.87	16.47	58.43
Common Stock	0	0	0	0	0
Additional Paid-In Capital	125.23	115.77	110.83	107.35	0.38
Retained Earnings	-144.18	-133.4	-110.94	-82.95	-52.74
Comprehensive Income & Other	-0.63	-0.43	-0.29	-0.63	-1.52
Shareholders' Equity	-19.59	-18.06	-0.4	23.78	-53.87
Total Liabilities & Equity	5.72	4.55	21.47	40.24	4.56
Total Debt	4.92	-	-	-	43.82
Net Cash (Debt)	-0.35	3.37	19.64	38.89	-41.13
Net Cash Growth	-	-82.85%	-49.51%	-	-
Net Cash Per Share	-0.09	0.98	5.83	14.94	-17.06
Filing Date Shares Outstanding	3.97	3.47	3.39	3.36	2.42
Total Common Shares Outstanding	3.96	3.46	3.39	3.35	2.42
Working Capital	-1.97	-7.8	7.72	23.17	-10.13
Book Value Per Share	-4.94	-5.22	-0.12	7.10	-22.28
Tangible Book Value	-19.59	-18.06	-0.4	23.78	-53.87
Tangible Book Value Per Share	-4.94	-5.22	-0.12	7.10	-22.28
Machinery	1.26	1.45	1.35	0.78	0.56

Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q